Feng He
Président chez Hrain Biotechnology Co., Ltd.
Postes actifs de Feng He
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Hrain Biotechnology Co., Ltd.
 Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Président | 18/06/2021 | - |
| Directeur/Membre du Conseil | - | 18/06/2021 | |
| Corporate Officer/Principal | - | 18/06/2021 |
Historique de carrière de Feng He
Formation de Feng He
| China Agricultural University | Graduate Degree |
Statistiques
Internationale
| Chine | 3 |
Opérationnelle
| Graduate Degree | 1 |
| Director/Board Member | 1 |
| Chairman | 1 |
Sectorielle
| Consumer Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Health Technology |
